Jia Sun

Jia Sun

Auto-generated profile, based on publicly available information

Jia Sun

National Resource Center for Mutant Mice, GemPharmatech Co., Ltd, Nanjing City 210023, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2023 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
JSJia Sun
Jia Sun
XWXinyuan Wang
Xinyuan Wang
RSRui Sun
Rui Sun
XXXiaoao Xiao
Xiaoao Xiao
YWYu Wang
Yu Wang
YGYuanqing Gao
Yuanqing Gao

1 January 2025 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
YWYixiao Wei
Yixiao Wei
JSJia Sun
Jia Sun
RZRuigong Zhu
Ruigong Zhu
Recent advances in epigenetics have elucidated the pivotal roles of epigenetic modifications in genomic regulation and disease pathogenesis. Concurrently, CRISPR-based technologies have transcended conventional gene-editing applications and have emerged as powerful tools for target gene screening, chromatin imaging, and epigenetic modulation. Notably, epigenetic landscapes substantially influence the CRISPR editing efficiency, whereas CRISPR itself can reshape epigenetic states, forming a dynamic CRISPR-Epigenetics Regulatory Circuit. This review systematically examines the bidirectional interplay between CRISPR systems and epigenetic modifications, emphasizing their collective impact on genome-editing precision, disease progression, and therapeutic development. Existing studies have predominantly focused on the application of CRISPR in epigenetic modifications or the impact of epigenetic landscapes on CRISPR, exhibiting unidirectional characteristics. However, accumulating evidence suggests a bidirectional interaction between the two. Here, a transformative "CRISPR-Epigenetics Regulatory Circuit" model is synthesized and presented, supported by three pivotal breakthroughs: demonstrating CRISPR as an active epigenetic programmer, synthesizing the epigenetic preconditioning therapeutic paradigm, and elucidating the first predictive mathematical model (EPIGuide). Further exploration of this circuit is expected to enhance CRISPR performance, optimize sgRNA design via epigenetic predictive models, and pioneer sequential epigenetic or gene editing therapies.

10 April 2026 in Food Chemistry: X
Verified
Journal Article
Open access
TFTianming Feng
Tianming Feng
YWYixiao Wei
Yixiao Wei
ZWZihan Wang
Zihan Wang
JSJia Sun
Jia Sun
RZRuigong Zhu
Ruigong Zhu
Cardiovascular Disease (CVD) is the leading cause of death globally, resulting in approximately 17.9 million deaths each year, which accounts for 32% of total deaths worldwide. Its pathogenesis involves the intricate interactions of genetic susceptibility, environmental factors, and lifestyle behaviors, among which smoking, hypertension, and hyperlipidemia are well-recognized core risk factors. In the field of nutritional research related to CVD, there has been a notable shift from focusing on individual nutrients to evaluating overall dietary patterns and their interactive effects with other health determinants. Based on this research paradigm shift, this review synthesizes the latest evidence regarding the roles and mechanisms of diet-related factors in CVD prevention and management, designing personalized dietary interventions by clarifying the cardiovascular protective mechanisms of these dietary factors, thereby supporting efforts to alleviate the global burden of CVD.